Interventional cardiology is numerous non-surgical processes for treating cardiovascular related problems. These procedures use flexible tubes and catheters thin to get way inside blood vessels to perform diagnostic test or to repair heart structures or other damaged vessels, often evading the need to have a surgical operation. Several devices used in these procedures include stent, PTCA balloon and catheters among several others. The diseases that are treated using interventional cardiology comprise coronary artery diseases, peripheral vascular disease and heart valve disease mainly.
Growth in geriatric population is expected to boost the market growth in the near future. Moreover increasing coronary artery disease is presumed to further propel the industry growth over the next eight year period Rise in demand for minimal procedures related with invasive angioplasty. Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period. Development and innovation in interventional cardiology has resulted in increased efficiency thus is presumed to be a major factor to fuel the market demand over the next seven years period.
This report provides a complete quantitative data and qualitative analysis on the global market for Interventional Cardiology Devices. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Interventional Cardiology Devices was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Interventional Cardiology Devices is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Interventional Cardiology Devices, including the following market information:
Global Interventional Cardiology Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Abbott, Acrostak, B. Braun Melsungen, Biosensors International, Boston Scientific Corporation, Cordis Corporation, Edwards Lifesciences Corporation, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Based on the Application:
Hospitals
Ambulatory Surgical Centers
Growth in geriatric population is expected to boost the market growth in the near future. Moreover increasing coronary artery disease is presumed to further propel the industry growth over the next eight year period Rise in demand for minimal procedures related with invasive angioplasty. Research and development across the world for technological advancement in order to achieve competitive advantage is estimated to further fuel the market demand over the forecast period. Development and innovation in interventional cardiology has resulted in increased efficiency thus is presumed to be a major factor to fuel the market demand over the next seven years period.
This report provides a complete quantitative data and qualitative analysis on the global market for Interventional Cardiology Devices. Market size is analysed by country, product type, application, and competitors. Expanded coverage includes additional end-user industry breakdowns and in-depth producer profiles.
Prior to COVID-19, the global market for Interventional Cardiology Devices was anticipated to grow from US$ XX million in 2020 to US$ XX million by 2026; it is expected to grow at a CAGR of xx% during 2021–2026, whereas post-COVID-19 scenario, the market for Interventional Cardiology Devices is projected to grow from US$ XX million in 2020 (a change by ~XX% compared to market estimated for 2020 before the outbreak of COVID-19) to US$ XX billion by 2026; it is expected to grow at a CAGR of XX% during 2021–2026.
This report covers market size and forecasts of Interventional Cardiology Devices, including the following market information:
Global Interventional Cardiology Devices Market Size, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Type and by Application, 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Region (and Key Countries), 2019-2021, and 2020 (quarterly data), (US$ Million)
Global Interventional Cardiology Devices Market Size by Company, 2019- 2020 (quarterly data), (US$ Million)
Key market players
Major competitors identified in this market include Abbott, Acrostak, B. Braun Melsungen, Biosensors International, Boston Scientific Corporation, Cordis Corporation, Edwards Lifesciences Corporation, etc.
Based on the Region:
Asia-Pacific (China, Japan, South Korea, India and ASEAN)
North America (US and Canada)
Europe (Germany, France, UK and Italy)
Rest of World (Latin America, Middle East & Africa)
Based on the Type:
Angioplasty Balloons
Angioplasty Stents
Catheters
Plaque Modification Devices
Hemodynamic Flow Alteration Devices
Based on the Application:
Hospitals
Ambulatory Surgical Centers
1.1 Research Scope
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Interventional Cardiology Devices Industry
1.7 COVID-19 Impact: Interventional Cardiology Devices Market Trends
2 Global Interventional Cardiology Devices Quarterly Market Size Analysis
2.1 Interventional Cardiology Devices Business Impact Assessment - COVID-19
2.1.1 Global Interventional Cardiology Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Interventional Cardiology Devices Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Interventional Cardiology Devices Quarterly Market Size, 2019 VS 2020
3.2 By Players, Interventional Cardiology Devices Headquarters and Area Served
3.3 Date of Key Players Enter into Interventional Cardiology Devices Market
3.4 Key Players Interventional Cardiology Devices Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Interventional Cardiology Devices Segments, By Type
4.1 Introduction
1.4.1 Angioplasty Balloons
1.4.2 Angioplasty Stents
1.4.3 Catheters
1.4.4 Plaque Modification Devices
1.4.5 Hemodynamic Flow Alteration Devices
4.2 By Type, Global Interventional Cardiology Devices Market Size, 2019-2021
5 Impact of Covid-19 on Interventional Cardiology Devices Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Ambulatory Surgical Centers
5.2 By Application, Global Interventional Cardiology Devices Market Size, 2019-2021
5.2.1 By Application, Global Interventional Cardiology Devices Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Interventional Cardiology Devices Quarterly Revenue, 2020
7.1.3 Abbott Interventional Cardiology Devices Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 Acrostak
7.2.1 Acrostak Business Overview
7.2.2 Acrostak Interventional Cardiology Devices Quarterly Revenue, 2020
7.2.3 Acrostak Interventional Cardiology Devices Product Introduction
7.2.4 Acrostak Response to COVID-19 and Related Developments
7.3 B. Braun Melsungen
7.3.1 B. Braun Melsungen Business Overview
7.3.2 B. Braun Melsungen Interventional Cardiology Devices Quarterly Revenue, 2020
7.3.3 B. Braun Melsungen Interventional Cardiology Devices Product Introduction
7.3.4 B. Braun Melsungen Response to COVID-19 and Related Developments
7.4 Biosensors International
7.4.1 Biosensors International Business Overview
7.4.2 Biosensors International Interventional Cardiology Devices Quarterly Revenue, 2020
7.4.3 Biosensors International Interventional Cardiology Devices Product Introduction
7.4.4 Biosensors International Response to COVID-19 and Related Developments
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Business Overview
7.5.2 Boston Scientific Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.5.3 Boston Scientific Corporation Interventional Cardiology Devices Product Introduction
7.5.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.6 Cordis Corporation
7.6.1 Cordis Corporation Business Overview
7.6.2 Cordis Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.6.3 Cordis Corporation Interventional Cardiology Devices Product Introduction
7.6.4 Cordis Corporation Response to COVID-19 and Related Developments
7.7 Edwards Lifesciences Corporation
7.7.1 Edwards Lifesciences Corporation Business Overview
7.7.2 Edwards Lifesciences Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.7.3 Edwards Lifesciences Corporation Interventional Cardiology Devices Product Introduction
7.7.4 Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
1.2 Market Segmentation
1.3 Research Objectives
1.4 Research Methodology
1.4.1 Research Process
1.4.2 Data Triangulation
1.4.3 Research Approach
1.4.4 Base Year
1.5 Coronavirus Disease 2019 (Covid-19) Impact Will Have a Severe Impact on Global Growth
1.5.1 Covid-19 Impact: Global GDP Growth, 2019, 2020 and 2021 Projections
1.5.2 Covid-19 Impact: Commodity Prices Indices
1.5.3 Covid-19 Impact: Global Major Government Policy
1.6 The Covid-19 Impact on Interventional Cardiology Devices Industry
1.7 COVID-19 Impact: Interventional Cardiology Devices Market Trends
2 Global Interventional Cardiology Devices Quarterly Market Size Analysis
2.1 Interventional Cardiology Devices Business Impact Assessment - COVID-19
2.1.1 Global Interventional Cardiology Devices Market Size, Pre-COVID-19 and Post- COVID-19 Comparison, 2015-2026
2.2 Global Interventional Cardiology Devices Quarterly Market Size 2020-2021
2.3 COVID-19-Driven Market Dynamics and Factor Analysis
2.3.1 Drivers
2.3.2 Restraints
2.3.3 Opportunities
2.3.4 Challenges
3 Quarterly Competitive Assessment, 2020
3.1 By Players, Global Interventional Cardiology Devices Quarterly Market Size, 2019 VS 2020
3.2 By Players, Interventional Cardiology Devices Headquarters and Area Served
3.3 Date of Key Players Enter into Interventional Cardiology Devices Market
3.4 Key Players Interventional Cardiology Devices Product Offered
3.5 Mergers & Acquisitions, Expansion Plans
4 Impact of Covid-19 on Interventional Cardiology Devices Segments, By Type
4.1 Introduction
1.4.1 Angioplasty Balloons
1.4.2 Angioplasty Stents
1.4.3 Catheters
1.4.4 Plaque Modification Devices
1.4.5 Hemodynamic Flow Alteration Devices
4.2 By Type, Global Interventional Cardiology Devices Market Size, 2019-2021
5 Impact of Covid-19 on Interventional Cardiology Devices Segments, By Application
5.1 Overview
5.5.1 Hospitals
5.5.2 Ambulatory Surgical Centers
5.2 By Application, Global Interventional Cardiology Devices Market Size, 2019-2021
5.2.1 By Application, Global Interventional Cardiology Devices Market Size by Application, 2019-2021
6 Geographic Analysis
6.1 Introduction
6.2 North America
6.2.1 Macroeconomic Indicators of US
6.2.2 US
6.2.3 Canada
6.3 Europe
6.3.1 Macroeconomic Indicators of Europe
6.3.2 Germany
6.3.3 France
6.3.4 UK
6.3.5 Italy
6.4 Asia-Pacific
6.4.1 Macroeconomic Indicators of Asia-Pacific
6.4.2 China
6.4.3 Japan
6.4.4 South Korea
6.4.5 India
6.4.6 ASEAN
6.5 Rest of World
6.5.1 Latin America
6.5.2 Middle East and Africa
7 Company Profiles
7.1 Abbott
7.1.1 Abbott Business Overview
7.1.2 Abbott Interventional Cardiology Devices Quarterly Revenue, 2020
7.1.3 Abbott Interventional Cardiology Devices Product Introduction
7.1.4 Abbott Response to COVID-19 and Related Developments
7.2 Acrostak
7.2.1 Acrostak Business Overview
7.2.2 Acrostak Interventional Cardiology Devices Quarterly Revenue, 2020
7.2.3 Acrostak Interventional Cardiology Devices Product Introduction
7.2.4 Acrostak Response to COVID-19 and Related Developments
7.3 B. Braun Melsungen
7.3.1 B. Braun Melsungen Business Overview
7.3.2 B. Braun Melsungen Interventional Cardiology Devices Quarterly Revenue, 2020
7.3.3 B. Braun Melsungen Interventional Cardiology Devices Product Introduction
7.3.4 B. Braun Melsungen Response to COVID-19 and Related Developments
7.4 Biosensors International
7.4.1 Biosensors International Business Overview
7.4.2 Biosensors International Interventional Cardiology Devices Quarterly Revenue, 2020
7.4.3 Biosensors International Interventional Cardiology Devices Product Introduction
7.4.4 Biosensors International Response to COVID-19 and Related Developments
7.5 Boston Scientific Corporation
7.5.1 Boston Scientific Corporation Business Overview
7.5.2 Boston Scientific Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.5.3 Boston Scientific Corporation Interventional Cardiology Devices Product Introduction
7.5.4 Boston Scientific Corporation Response to COVID-19 and Related Developments
7.6 Cordis Corporation
7.6.1 Cordis Corporation Business Overview
7.6.2 Cordis Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.6.3 Cordis Corporation Interventional Cardiology Devices Product Introduction
7.6.4 Cordis Corporation Response to COVID-19 and Related Developments
7.7 Edwards Lifesciences Corporation
7.7.1 Edwards Lifesciences Corporation Business Overview
7.7.2 Edwards Lifesciences Corporation Interventional Cardiology Devices Quarterly Revenue, 2020
7.7.3 Edwards Lifesciences Corporation Interventional Cardiology Devices Product Introduction
7.7.4 Edwards Lifesciences Corporation Response to COVID-19 and Related Developments
8 Key Findings
9 Appendix
9.1 About US
9.2 Disclaimer
